Author + information
- Received June 25, 1985
- Revision received February 4, 1986
- Accepted February 10, 1986
- Published online August 1, 1986.
- ↵*Address for reprints: Rosemarie Salerni, MD, Division of Cardiology, University of Pittsburgh, 789 Scaife Hall, Pittsburgh, Pennsylvania 15261.
A patient who developed severe iron overload cardiomyopathy is described. Venesection could not be performed because the patient had chronic anemia. Deferoxamine mesylate, a chelating agent, was administered daily for more than 2 years and produced significant improvement in ventricular function which was associated with a biopsy-proven decrease in myocardial iron stores. This is the first reported case in which a severe cardiomyopathy due to iron overload was reversed by chelation therapy alone.
- Received June 25, 1985.
- Revision received February 4, 1986.
- Accepted February 10, 1986.
- American College of Cardiology Foundation